Test:

CA 242 oncomarker (colorectal cancer) 

Price is 6760 tenge

All these symptoms - changes in the large intestine (diarrhea or constipation), blood clots in the feces, abdominal pain or discomfort, unexplained weight loss, weakness and fatigue - can be signs of colorectal cancer.

Colorectal cancer is a malignant growth that develops in the large intestine (colon) or rectum. It is often referred to simply as colon cancer. Colorectal cancer is among the most common cancers of the large intestine, and early diagnosis greatly increases the likelihood of successful treatment.

Analyses have shown that the CA 242 oncomarker has a number of advantages over other oncomarkers which are:

• High specificity: CA 242 is highly accurate in detecting malignant tumors, which reduces the likelihood of false positive results.
• Early diagnosis: Elevated levels of CA 242 can be detected in the early cancer, which allows to start treatment before symptoms appear.
• Treatment monitoring: CA 242 levels can be used to monitor the effectiveness of therapy and to detect recurrences early.

Recent analyses conducted at leading cancer centers confirm the importance of CA 242 in clinical practice. In particular, these analyses show that the combined use of CA 242 with other oncomarkers, such as CA 19-9 and CEA, significantly improves the accuracy of cancer diagnosis and monitoring.

Sampling material is venous blood

The test is available in all treatment rooms through Kazakhstan